Drugs / Eliprodil
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00001929 | Mar 1999 → Jan 2001 | Parkinson disease, movement disorder | National Institute of Neurological Disorders and Stroke (NINDS) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Eliprodil | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00001929 ↗ |
| Action | Inhibit | “Eliprodil works by blocking special receptors (NMDA)” NCT00001929 ↗ |
| Modality | Small molecule | — CHEMBL28564 ↗ |